2B8R1F8: Rhesus recombinant, CDR-grafted, afucosylated IgG1-kappa anti-CD20 antibody. Derived from rituximab.
How to cite this reagent
For your Materials & Methods section:
The rhesus IgG1 recombinant Anti-CD20 [2B8R1F8]-Afucosylated monoclonal antibody was engineered and produced by the Nonhuman Primate Reagent Resource (NIH Nonhuman Primate Reagent Resource Cat# PR-8288, RRID:AB_2819341).
For your Acknowledgements section:
"The Anti-CD20 [2B8R1F8]-Afucosylated antibody used in this study was provided by the NIH Nonhuman Primate Reagent Resource (P40 OD028116)".
|